04/08/2008 08:03:14 AM EST
Boston Scientific Announces Appointment of Timothy Pratt as General Counsel
NATICK, Mass. – Boston Scientific Corporation today announced the appointment of Timothy Pratt as its new General Counsel. Pratt is a nationally known attorney specializing in medical device and pharmaceutical litigation. He will hold the title of "Executive Vice President, Secretary and General Counsel;" he will serve on the Company's Executive Committee, and he will report to President and Chief Executive Officer Jim Tobin. He plans to join the Company May 1st.
Pratt comes to Boston Scientific after 31 years with the Kansas City law firm of Shook, Hardy & Bacon, where he has been a partner and co-chair of the firm's 100-attorney Pharmaceutical and Medical Device Litigation Division. He has a broad range of experience representing a variety of medical device and pharmaceutical companies, and he has received numerous recognitions for his accomplishments.
Pratt has focused his practice on cardiac devices, including pacemakers, defibrillators and cardiac resynchronization therapy devices. He has served as lead outside counsel for Guidant Corporation's Cardiac Rhythm Management business since the early 1990s. Boston Scientific acquired Guidant in 2006.
Prior to joining Shook, Hardy & Bacon, he was a law clerk to Chief Judge Floyd R. Gibson of the U.S. Court of Appeals for the Eighth Circuit.
Pratt is a graduate of Drake University Law School, where he was Editor in Chief of the Law Review.
Pratt replaces Paul Sandman, who retired as General Counsel in February after 14 years with the Company.
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com/.